# Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer

> **NCT02107404** · PHASE2 · COMPLETED · sponsor: **SOTIO a.s.** · enrollment: 150 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Dendritic Cells DCVAC/PCa

## Key facts

- **NCT ID:** NCT02107404
- **Lead sponsor:** SOTIO a.s.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-06
- **Final completion:** 2017-05-22
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02107404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02107404, "Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02107404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*